Abstract
Parkinsons disease (PD) is characterized by the selective loss of dopamine (DA) neurons in the substantia nigra compacta (SNc). The transcription factor Pitx3 is important for the differentiation and maintenance of midbrain DA neurons during development. There is highly restricted and constitutive expression of Pitx3 in the SNc and ventral tegmental area (VTA) of the midbrain after birth. In addition to its importance during development, Pitx3 also has roles in the long-term survival and maintenance of the midbrain DA neurons. In this review, we discuss the function of Pitx3 throughout the life of midbrain neurons and the contribution of Pitx3 to disease mechanisms.
Keywords: Mesostriatal, substantia nigra, pituitary homeobox, transcription factor 3, Rieg1, parkinsonian, Nurr1, aphakia
Current Topics in Medicinal Chemistry
Title: The Role of Transcription Factor Pitx3 in Dopamine Neuron Development and Parkinsons Disease
Volume: 9 Issue: 10
Author(s): Jia Li, John A. Dani and Weidong Le
Affiliation:
Keywords: Mesostriatal, substantia nigra, pituitary homeobox, transcription factor 3, Rieg1, parkinsonian, Nurr1, aphakia
Abstract: Parkinsons disease (PD) is characterized by the selective loss of dopamine (DA) neurons in the substantia nigra compacta (SNc). The transcription factor Pitx3 is important for the differentiation and maintenance of midbrain DA neurons during development. There is highly restricted and constitutive expression of Pitx3 in the SNc and ventral tegmental area (VTA) of the midbrain after birth. In addition to its importance during development, Pitx3 also has roles in the long-term survival and maintenance of the midbrain DA neurons. In this review, we discuss the function of Pitx3 throughout the life of midbrain neurons and the contribution of Pitx3 to disease mechanisms.
Export Options
About this article
Cite this article as:
Li Jia, Dani A. John and Le Weidong, The Role of Transcription Factor Pitx3 in Dopamine Neuron Development and Parkinsons Disease, Current Topics in Medicinal Chemistry 2009; 9 (10) . https://dx.doi.org/10.2174/156802609789378236
DOI https://dx.doi.org/10.2174/156802609789378236 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cognitive Impairment in Systemic Lupus Erythematosus: Prevalence and Clinical Importance
Current Rheumatology Reviews Lipid-Lowering Drugs Acting at the Level of the Gastrointestinal Tract
Current Pharmaceutical Design Triple Antiplatelet Therapy after PCI - Should or Could it be Done?
Cardiovascular & Hematological Disorders-Drug Targets Mechanisms, Prevention and Treatment of Distal Embolization
Current Pharmaceutical Design COVID-19: An Update on Pathogenesis and Treatment
Current Pharmaceutical Design Advanced Glycation End Products and Cardiovascular Disease
Current Diabetes Reviews Surgical or Interventional Revascularization in Diabetic Patients with Coronary Artery Disease?
Current Diabetes Reviews Pharmacogenomic Considerations in the Treatment of the Pediatric Cardiomyopathy Called Barth Syndrome
Recent Patents on Biotechnology Tolvaptan: A New Therapeutic Agent
Reviews on Recent Clinical Trials How to Investigate the Vascular Changes in Resistant Hypertension
Current Hypertension Reviews Diabetic Cardiomyopathy: Electromechanical Cellular Alterations
Current Vascular Pharmacology Arterial Stiffness, Pulse Wave Analyses: What Can’t Blood Pressure Tell you in Chronic Kidney Disease
Current Hypertension Reviews Expressions of eNOS3 and Ve-Cadherin in Microvascular Endothelium at 7-Day of Reperfused Acute Myocardial Infarction
Cardiovascular & Hematological Disorders-Drug Targets Monoclonal Antibodies in the Management of Solid Tumors
Current Topics in Medicinal Chemistry Preface [Hot topic: Anti-Hypertensive Agents in Relation to Modifying Coronary Risk Factors (Executive Editor : Aurelio Leone)]
Current Pharmaceutical Design Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) Effects of Physical Exercise on Inflammatory Markers of Atherosclerosis
Current Pharmaceutical Design Novel Molecular Targets in the Treatment of Cardiac Hypertrophy
Recent Patents on Cardiovascular Drug Discovery Long-Term Outcome of Cardio Respiratory Exercise Performance After Surgery
Current Respiratory Medicine Reviews Interatrial Block in the Modern Era
Current Cardiology Reviews